A multicenter 3 year open study of lamivudine in HBeAg negative chronic hepatitis B (interim report of the first year): Nicholaos Tassopoulos, Western Attica General Hospital, Athens Greece; Nicholaos Evgenidis Dr, Hippokration General Hospital, Thessaloniki Greece; George Kitis, G Papanikolaou General Hospital, Thessaloniki Greece; Sotiris Koutsounas, 1st IKA Hosp Pendeli, Athens Greece; John Elefsiniotis, Gyn & Obst Centre Elena Venizelou, Athens Greece; Stelios Karatapanis, Municipal Hospital of Athens Elpis, Athens Greece; Konstantine Arvanitakis, Hippokration General Hospital, Thessaloniki Greece; Irene Vafiadis, Laiko General Hospital, Athens Greece; Hlias Kouroumalis, Regional General University Hospital of Heraklion, Crete Greece; Spilios Manolakopoulos, Athens Policlinic, Athens Greece; Maria G Papaioannou, George Vogiatzis, GlaxoWellcome, Athens Greece